ArticleBMC bioinformatics2025
scFTAT: a novel cell annotation method integrating FFT and transformer.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundAdvancements in high-throughput sequencing and deep learning have boosted single-cell RNA studies. However, current methods for annotating single-cell data face challenges due to high data sparsity and tedious manual annotation on large-scale data.
resultsThus, we proposed a novel annotation model integrating FFT (Fast Fourier Transform) and an enhanced Transformer, named scFTAT. Initially, it reduces data sparsity using LDA (Linear Discriminant Analysis). Subsequently, automatic cell annotation is achieved through a proposed module integrating FFT and an enhanced Transformer. Moreover, the model is fine-tuned to improve training performance by effectively incorporating such techniques as kernel approximation, position encoding enhancement, and attention enhancement modules. Compared to existing popular annotation tools, scFTAT maintains high accuracy and robustness on six typical datasets. Specifically, the model achieves an accuracy of 0.93 on the human kidney data, with an F1 score of 0.84, precision of 0.96, recall rate of 0.80, and Matthews correlation coefficient of 0.89. The highest accuracy of the compared methods is 0.92, with an F1 score of 0.71, precision of 0.75, recall rate of 0.73, and Matthews correlation coefficient of 0.85. The compiled codes and supplements are available at: https://github.com/gladex/scFTAT .
conclusionIn summary, the proposed scFTAT effectively integrates FFT and enhanced Transformer for automatic feature learning, addressing the challenges of high sparsity and tedious manual annotation in single-cell profiling data. Experiments on six typical scRNA-seq datasets from human and mouse tissues evaluate the model using five metrics as accuracy, F1 score, precision, recall, and Matthews correlation coefficient. Performance comparisons with existing methods further demonstrate the efficiency and robustness of our proposed method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.